Emerging Clinical Issues in Novel Treatment Modalities - Video Series

Thank you for accessing the “Emerging Clinical Issues in Novel Treatment Modalities” video series!

This four-part series was designed to meet the current educational needs of prescribers faced with an increasingly complex and ever-evolving hemophilia treatment landscape with particular focus on the ‘non-factor’ products currently approved by the U.S. Food and Drug Administration as well as emerging novel therapies still in development.

We would be delighted to receive your feedback!

Question Title

* 1. I watched the following video

"Understanding Mechanisms of Action and Utility of Novel Treatments for Hemophilia A and B”

“Shared Decision Making in the Age of Novel Technologies for Hemophilia”

“Managing Complex Cases with Novel Non-Factor Therapies"

"Navigating Reimbursement for Patients on Non-Factor Therapy”

Question Title

* 2. I am

Someone who prescribes therapies for patients with bleeding disorders

Someone who works with patients at a hemophilia treatment center (HTC)

A healthcare professional working outside the HTC network

Someone who does not treat patients with bleeding disorders

An individual or family member affected by a bleeding disorder

Question Title

* 3. My knowledge of non-factor therapies was increased after watching this webinar activity.

Agree

Disagree

Question Title

* 4. My ability to make appropriate treatment decisions with patients on the use of non-factor products has been enhanced after watching this webinar.

Agree

Disagree

not applicable - I do not see patients

Emerging Clinical Issues in Novel Treatment Modalities - Video Series

Question Title

* 1. I watched the following video

Question Title

* 2. I am

Question Title

* 3. My knowledge of non-factor therapies was increased after watching this webinar activity.

Question Title

* 4. My ability to make appropriate treatment decisions with patients on the use of non-factor products has been enhanced after watching this webinar.

Question Title

* 5. Do you have any general comments to share regarding this particular learning activity and/or the overall program?